GAM Holding’s AngioDynamics ANGO Stock Holding History

GAM Holding’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-20,000	Closed	-$226K	–	1125
2013 Q2	$226K	Buy	+20,000	New	+$213K	﹤0.01%	735

Other funds holding ANGO

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GAM Holding's ANGO Position: Q3 2013 in Review

GAM Holding sold out of AngioDynamics (ANGO) in Q3 2013, closing a stake of 20,000 shares — an estimated $226K sold.

GAM Holding first reported a position in ANGO in Q2 2013 and held it in 1 quarter. The position peaked at $226K in Q2 2013. 91 funds tracked by Wall St. Rank hold ANGO as of Q3 2013.

GAM Holding reported no remaining AngioDynamics position as of Q3 2013 after selling out during the quarter.
GAM Holding sold 20,000 AngioDynamics shares in Q3 2013, an estimated $226K.
GAM Holding first reported a position in AngioDynamics in Q2 2013 and held it in 1 quarter.
GAM Holding's AngioDynamics position peaked at $226K in Q2 2013.
91 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2013.

Based on GAM Holding's 13F filing for Q3 2013, filed 12 Nov 2013.